Innovations and Incentives in the Life Sciences
Jordan Paradise, J.D.*
This Edition of Annals of Health Law features symposium articles resulting from the
Tenth Annual Symposium on Health Care and Policy co-sponsored with the Beazley Institute for
Health Law and Policy at the Loyola University Chicago School of Law.
1 The symposium
hosted scholars and regulatory experts with the goal of exploring legal and policy challenges
with emerging research and medical innovations in the life science realm. The symposium was
organized around three core topical panel sessions: mobile health and devices;
regulatory, and ethical issues surrounding gene editing technology;
3 and innovation and patient
4 Professor Rebecca Eisenberg, Robert and Barbara Luciano Professor of Law at the
University of Michigan Law School, delivered the keynote address on Promoting Diagnostics
Development through Medicare Coverage with Evidence Development.
Annals of Health Law and the Beazley Institute for Health Law and Policy recognize the
importance of rapid advancements in the life sciences and the social, economic, and legal and
policy implications that arise with their availability to the public. The symposium fostered
tremendous engagement and discussions on a wide-range of cutting-edge issues. As a means to
contribute to the continuing academic dialogue in life science law, we are pleased to share the
following articles resulting from the symposium:
• Rachel E. Sachs, Mobile Health Innovation and Interagency Collaboration
• Sam Halabi, Zika and the Regulatory Regime for Licensing Vaccines for Use During
• Barry Furrow, The CRISPR-Cas9 Tool of Gene Editing: Cheaper, Faster, Riskier?
• Katherine Macfarlane, Camouflaging State Biosimilar Laws as Pro-Patient Legislation
• Ana Santos Rutschman, The Priority Review Voucher Program at the FDA: From
Neglected Tropical Diseases to the 21st Century Cures Act
* Professor of Law, Loyola University Chicago School of Law.
1 The symposium was held on October 28, 2016 at Loyola University Chicago School of Law, Philip H.
Corboy Law Center.
2 Speakers were Rachel E. Sachs, Associate Professor of Law at the Washington University in St. Louis
School of Law; Tabrez Y. Ebrahim, Attorney at Bracewell, LLP; Janet Trunzo, Senior Executive Vice
President, Technology & Regulatory Affairs, AdvaMed;
3 Speakers were Barry Furrow, Professor and Director of Health Law Program at Drexel University
School of Law; Barbara Evans, Professor and Director of the Center on Biotechnology & Law at
University of Houston Law Center; Laurie Zoloth, Professor and Director of the Center for Bioethics,
Science and Society at the Feinberg School of Medicine.
4 Speakers were Ana Santos Rutschman, Jaharis Faculty Fellow in Health Law and Intellectual Property
at DePaul University College of Law; Katherine A. Macfarlane, Associate Professor of Law at the
University of Idaho College of Law; and Sam Halabi, Associate Professor for the University of Missouri
School of Law.